AGEN
#3166
Agenus Inc. - Common Stock
8.0 9 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.25%
Variación mensual
+5.75%
Variación en los últimos 6 meses
+148.16%
Cambio anual
+89.02%
Cierres anteriores
7.9 9
Open
8.0 1
Mínimo
7.9 5
Máximo
8.1 3
Volumen
298
Financials
- Market Capitalization 364.22 M
- Employee 81
- Founded 1999
- CEO N/A
- Website www.agenusbio.com
- Headquarter Delaware, United States
- FIGI BBG000C8SWQ9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
1.01
Relación precio/flujo de caja
0.81
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3151 |  IRD Opus Genetics, Inc. - Common Stock | 4.32 USD | +12.79% | +9.64% | +16.13% | +16.13% | 359.41 M USD | ||
| 3152 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 14.66 USD | +0.89% | -0.95% | +12.34% | -39.40% | 359.25 M USD | ||
| 3181 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.51 USD | +5.46% | +1.62% | +14.61% | +43.43% | 350.24 M USD | ||
| 3197 |  PALI Palisade Bio, Inc. - Common Stock | 1.98 USD | +1.02% | -6.60% | +4.21% | +16.47% | 345.06 M USD |